Multiple activated oxygen species in p450 catalysis. Contributions to specificity in drug metabolism

Drug Metabolism and Disposition

Volumn 26, Issue 12, 1998, Pages 1190-1193

  Coon, Minor J ^a,b   Vaz, Alfin D N ^a   Mcginnity, Dermot F ^a   Peng, Hwei Ming ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2B4; CYTOCHROME P450 2E1; CYTOCHROME P450 ISOENZYME; UNCLASSIFIED DRUG;

BACTERIUM; DRUG METABOLISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; GENE MUTATION; MAMMAL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; PHARMACEUTICAL PREPARATIONS; REACTIVE OXYGEN SPECIES; SUBSTRATE SPECIFICITY;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0032430067     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Akhtar M, Calder MR, Corina DL and Wright JN (1982) Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. Biochem J 201:569-580.
2. Carroll MA, Schwartzman M, Capdevila J, Falok JR and McGiff JC (1987) Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol 138:281-283.
3. Coon MJ, Vaz ADN and Bestervelt LL (1996) Peroxidative reactions of diversozymes. FASEB J 10:428-434.
4. Dahl GA, Miller J and Miller EC (1978) Vinyl carbamate as a promutagen and a more carcinogenic analog of ethyl carbamate. Cancer Res 38:3793-3804.
5. Deutsch J, Leutz JC, Yang SK, Gelboin HV, Chiang YL, Vatsis KP and Coon MJ (1978) Regio-and stereoselectivity of various forms of purified cytochrome P-450 in the metabolism of benzo[a]pyrene and (-)trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene as shown by product formation and binding to DNA. Proc Natl Acad Sci USA 75:3123-3127.
6. Gordon GB, Spielberg SP, Blake DA and Balasubramanian V (1981) Thalidomide teratogenesis: Evidence for a toxic arene oxide metabolite. Proc Natl Acad Sci USA 78:2545-2548.
7. Groves JT (1986) Biological strategies for the manipulation of dioxygen: The chemistry of cytochrome P-450. Ann NY Acad Sci 471:99-107.
8. Groves JT, McClusky GA, White RE and Coon MJ (1978) Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450: Evidence for a carbon radical intermediate. Biochem Biophys Res Commun 81:154-160.
9. Guengerich FP, and Kim D-H (1991) Enzymatic oxidation of ethyl carbamate to vinyl carbamate and its role as an intermediate in the formation of 1,N6-ethenoadcnosine. Chem Res Toxicol 4:413-421.
10. Guengerich FP and Macdonald TL (1990) Mechanisms of cytochrome P-450 catalysis. FASEB J 4:2453-2459.
11. Imai M, Shimada H, Watanabe Y, Matsushima-Hibiya Y, Makino R, Koga H, Horiuchi T and Ishimura Y (1989) Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine: Possible role of the hydroxy amino acid in oxygen activation. Proc Natl Acad Sci USA 86:7823-7827.
12. Kimata Y, Shimada H, Hirose T and Ishimura T (1995) Role of Thr-252 in cytochrome P450cam: A study with unnatural amino acid mutagenesis. Biochem Biophys Res Commun 208:96-102.
13. Kuo C-L, Vaz ADN and Coon MJ (1997) Metabolic activation of trans-4-hydroxy-2-nonenal, a toxic product of membrane lipid peroxidation and inhibitor of P450 cytochromes. J Biol Chem 272:22611-22616.
14. Martinis SA, Atkins WM, Stayton PS and Sligar SG (1989) A conserved residue of cytochrome-P-450 is involved in heme-oxygen stability and activation. J Am Chem Soc 111:9252-9253.
15. Martz F, Faillinger C and Blake DA (1977) Phenytoin teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue. J Pharmacol Exp Ther 203:231-239.
16. Mitchell JR, Nelson WL, Potter WZ, Sasame HA and Jollow DL (1976) Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther 199:41-52.
17. Raag R, Martinis SA. Sligar SG and Poulos TL (1991) Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. Biochemistry 30:11420-11429.
18. Raner GM, Vaz ADN and Coon MJ (1996) Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral. Mol Pharmacol 49:515-522.